Crestor (Rosuvastatin) Cost in Louisiana: 2026 Prices, Insurance, and Savings

What Does Rosuvastatin Actually Cost in Louisiana in 2026?

Generic rosuvastatin averages roughly $15 per month at Louisiana retail pharmacies, making it one of the most affordable statins available. Brand-name Crestor carries a manufacturer list price near $290 per month from AstraZeneca, though almost no patient pays that figure out of pocket thanks to generic substitution, insurance formulary placement, and discount programs.

Brand vs. Generic Price Gap

The price difference between Crestor and its generic equivalent is roughly 19:1. Since rosuvastatin lost patent exclusivity in 2016, multiple generic manufacturers (including Teva, Sandoz, and Aurobindo) have entered the market. Competition pushed cash-pay prices below $20 per month at most Louisiana chains, including Walgreens, CVS, Walmart, and Winn-Dixie pharmacies.

For patients filling a 90-day supply at Walmart or Costco, the price often drops below $10 per month. Mark Cuban's Cost Plus Drugs lists rosuvastatin at its acquisition cost plus a flat markup and $5 dispensing fee, which frequently undercuts traditional retail pricing.

How List Price Differs From What You Pay

AstraZeneca's $290 list price applies to the branded Crestor tablet before any rebates, discounts, or insurance adjustments. Louisiana law requires pharmacies to offer generic substitution unless the prescriber writes "dispense as written," so most patients automatically receive generic rosuvastatin. The practical out-of-pocket cost for an uninsured Louisiana resident filling generic rosuvastatin is $12 to $22 per month depending on dose and pharmacy, according to GoodRx pricing data for the Baton Rouge, New Orleans, and Shreveport metro areas.

Dose and Cost Relationship

Rosuvastatin tablets are available in 5 mg, 10 mg, 20 mg, and 40 mg strengths. Pricing across strengths is relatively flat for generics. A 30-count supply of 5 mg tablets typically costs within $2 of the same quantity of 20 mg tablets at major Louisiana pharmacies. This flat pricing structure means dose titration has minimal impact on monthly expenses for generic users.

Louisiana Medicaid and Rosuvastatin Coverage

Louisiana Medicaid does not cover brand-name Crestor on its preferred drug list. This exclusion applies across Medicaid managed care organizations operating in the state, including Healthy Blue, Aetna Better Health of Louisiana, AmeriHealth Caritas Louisiana, Louisiana Healthcare Connections, and UnitedHealthcare Community Plan.

What Medicaid Does Cover

Generic rosuvastatin is available through Louisiana Medicaid, though coverage is managed through each MCO's formulary and may require the prescriber to use the generic name on the prescription. Prior authorization is generally not required for first-line statin therapy when prescribed for FDA-approved indications including primary hyperlipidemia and mixed dyslipidemia.

Navigating Prior Authorization

If a prescriber believes brand Crestor is medically necessary (for example, due to a documented intolerance to generic formulations), a prior authorization request can be submitted to the patient's Medicaid MCO. Approval rates for brand-over-generic exceptions vary. The Louisiana Department of Health's Drug Utilization Review Board periodically updates clinical criteria for statin coverage decisions.

Louisiana Medicaid enrollees who face formulary restrictions should ask their prescriber about therapeutic alternatives. Atorvastatin (generic Lipitor) is covered by most Louisiana Medicaid MCOs at preferred-tier status and offers comparable LDL-C reduction at high-intensity doses. The 2018 AHA/ACC cholesterol guideline classifies both rosuvastatin 20 to 40 mg and atorvastatin 40 to 80 mg as high-intensity statin therapy.

Insurance Coverage for Crestor and Rosuvastatin in Louisiana

Most commercial insurance plans in Louisiana place generic rosuvastatin on Tier 1 (preferred generic), which typically carries a $0 to $15 copay. Brand Crestor, when covered at all, sits on Tier 3 or higher with copays ranging from $50 to $150 per month depending on the plan.

Major Carriers and Formulary Placement

Blue Cross Blue Shield of Louisiana, the state's largest commercial insurer, includes generic rosuvastatin on its preferred generic tier across most plan designs. UnitedHealthcare, Humana, Aetna, and Cigna plans sold in the Louisiana marketplace similarly cover generic rosuvastatin without prior authorization.

Medicare Part D plans in Louisiana almost universally cover generic rosuvastatin. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap that took full effect in 2025, Medicare beneficiaries filling rosuvastatin will rarely approach that threshold from this drug alone, given its low monthly cost.

Employer-Sponsored Plans

Large employer plans in Louisiana's major industries (petrochemical, healthcare, shipping, and energy) typically negotiate even lower copays for generic statins. Many self-insured employer plans cover rosuvastatin at $0 copay as a preventive medication under the ACA preventive services mandate, which requires first-dollar coverage for statin therapy in adults aged 40 to 75 with cardiovascular risk factors and no history of CVD, based on the USPSTF Grade B recommendation.

Compounded Rosuvastatin in Louisiana: Legality and Access

Compounded rosuvastatin is legal in Louisiana through licensed 503A pharmacies. These pharmacies operate under state Board of Pharmacy oversight and prepare individualized prescriptions based on a valid patient-prescriber relationship.

503A vs. 503B Compounding

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients with valid prescriptions. Section 503B covers outsourcing facilities that produce larger batches under FDA oversight. Both pathways are available in Louisiana for rosuvastatin compounding.

A 503A compounded rosuvastatin preparation may be appropriate for patients who need a non-standard dose (such as 7.5 mg or 15 mg), require a liquid suspension due to swallowing difficulties, or have allergies to inactive ingredients in the commercial tablet. The Louisiana Board of Pharmacy regulates compounding pharmacies and requires compliance with USP Chapter 795 standards for non-sterile preparations.

Cost of Compounded Rosuvastatin

Compounded rosuvastatin pricing varies by pharmacy. Some 503A pharmacies offer compounded formulations at or near $0 as part of membership-based or direct-primary-care arrangements. Others charge $20 to $40 per month depending on the formulation complexity. Because compounded drugs are not FDA-approved finished products, insurance coverage is inconsistent. Patients should verify coverage with their plan before filling.

The JUPITER Trial and Why Rosuvastatin Pricing Matters

The landmark JUPITER trial (N=17,802) established rosuvastatin 20 mg as a preventive therapy for apparently healthy individuals with elevated high-sensitivity C-reactive protein (hsCRP ≥ 2 mg/L) and LDL-C <130 mg/dL. Published in the New England Journal of Medicine in 2008, JUPITER demonstrated a 44% reduction in the primary composite endpoint of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or cardiovascular death over a median follow-up of 1.9 years [1].

Clinical Significance for Louisiana

Louisiana ranks among the top ten states for cardiovascular mortality, according to CDC data on heart disease death rates. The state's age-adjusted heart disease death rate exceeds the national average by approximately 20%. Affordable access to high-intensity statin therapy has direct public health relevance here.

"Rosuvastatin is the most potent statin available on a milligram-for-milligram basis, achieving up to 55% LDL-C reduction at the 40 mg dose," per the ACC/AHA guideline on the management of blood cholesterol. For Louisiana residents with elevated ASCVD risk, the combination of low generic pricing and broad insurance coverage removes most financial barriers to treatment initiation.

Number Needed to Treat

In JUPITER, the number needed to treat (NNT) to prevent one primary endpoint event over 1.9 years was 95 for the overall population [1]. For patients with additional risk factors (metabolic syndrome, family history, elevated hsCRP), the NNT drops substantially. At $15 per month for generic rosuvastatin, the cost per prevented cardiovascular event is among the lowest of any preventive intervention in cardiology.

Telehealth Prescribing of Rosuvastatin in Louisiana

Louisiana permits telehealth prescribing of rosuvastatin statewide. The Louisiana State Board of Medical Examiners allows physicians and advanced practice providers to prescribe non-controlled medications, including statins, via synchronous audio-video telemedicine visits.

How Telehealth Prescribing Works

A licensed Louisiana prescriber (or a provider licensed in a state with an active interstate compact agreement) can evaluate a patient's lipid panel, assess cardiovascular risk, and prescribe rosuvastatin without an in-person visit. The prescription is sent electronically to the patient's preferred pharmacy.

Several telehealth platforms serve Louisiana residents for statin management, including HealthRX, which offers clinician-guided lipid management with lab ordering and prescription fulfillment. Telehealth visits typically cost $30 to $75 without insurance, and many commercial plans cover telemedicine at the same copay as in-person primary care.

Lab Monitoring Requirements

Statin therapy requires baseline and follow-up lipid panels. The 2018 AHA/ACC guideline recommends a fasting lipid panel 4 to 12 weeks after starting or adjusting statin therapy, and then every 3 to 12 months thereafter. Louisiana has a patient-direct lab testing law that allows residents to order certain blood tests without a physician order, though most telehealth platforms include lab orders as part of the visit.

A hepatic function panel (ALT) should be checked at baseline. Routine monitoring of liver enzymes during statin therapy is no longer recommended by the FDA's updated rosuvastatin labeling unless clinically indicated [2].

How to Get the Lowest Price on Rosuvastatin in Louisiana

The cheapest path depends on your insurance status and preferred pharmacy. Here is a practical breakdown.

Uninsured or High-Deductible Plan

Use a pharmacy discount card (GoodRx, RxSaver, or SingleCare) at a Louisiana Walmart, Costco, or independent pharmacy. Expect to pay $8 to $18 per month for generic rosuvastatin. Walmart's $4/$10 generic program historically included rosuvastatin, though availability varies by location.

Commercially Insured

Fill generic rosuvastatin at your plan's preferred pharmacy. Tier 1 copay is typically $0 to $15. If your plan covers statin therapy as a preventive service under the USPSTF Grade B recommendation, your copay may be $0 regardless of deductible status [3].

Medicare Part D

Generic rosuvastatin is covered on most Part D formularies. With the $2,000 annual out-of-pocket cap, total statin spending is capped even for patients on multiple medications.

Manufacturer Savings Card

AstraZeneca offers a Crestor savings card for commercially insured patients who require the brand product. Eligible patients may pay as little as $3 per month, though this card does not apply to government insurance (Medicare, Medicaid, Tricare, VA). The savings card is available at crestor.com and can be presented at any Louisiana pharmacy.

503A Compounding

For patients needing a custom formulation, licensed 503A pharmacies in Louisiana can compound rosuvastatin at variable pricing. Contact the pharmacy directly for a quote, as compounded medication pricing is not standardized.

Safety Considerations at Louisiana-Relevant Doses

Rosuvastatin is generally well tolerated across the 5 to 40 mg dose range. The most common adverse effects in clinical trials were myalgia (reported in 2% to 5% of patients), headache, abdominal pain, and nausea [2].

Myopathy Risk

The FDA label warns about the rare risk of rhabdomyolysis, particularly at the 40 mg dose and in patients of Asian descent, who exhibit approximately twofold higher rosuvastatin plasma concentrations. The recommended starting dose for Asian patients is 5 mg [2]. Louisiana prescribers should be aware that the state has a growing Vietnamese and Southeast Asian population, particularly in the New Orleans metro area, where dose adjustment may be clinically relevant.

Diabetes Risk

The JUPITER trial identified a statistically significant increase in physician-reported diabetes among rosuvastatin-treated patients (2.8% vs. 2.3% with placebo, P=0.01) [1]. A 2010 meta-analysis published in The Lancet (N=91,140 across 13 statin trials) found a 9% relative increase in diabetes incidence with statin therapy, corresponding to one additional diabetes case per 255 patients treated for 4 years [4]. The cardiovascular benefit outweighs this risk in patients who meet prescribing criteria.

"The net cardiovascular benefit of statin therapy substantially exceeds the diabetes hazard in patients with indications for treatment," according to the 2018 AHA/ACC cholesterol guideline [3].

Drug Interactions Relevant to Louisiana Prescribing Patterns

Rosuvastatin has fewer CYP450-mediated interactions than atorvastatin or simvastatin, but several interactions warrant attention.

Cyclosporine

Concomitant use with cyclosporine increases rosuvastatin AUC approximately sevenfold. Rosuvastatin dose should not exceed 5 mg daily in patients taking cyclosporine [2].

Gemfibrozil

Combining rosuvastatin with gemfibrozil roughly doubles rosuvastatin exposure. If combination therapy is necessary, the rosuvastatin dose should not exceed 10 mg daily [2].

Antacids

Simultaneous administration of aluminum-and-magnesium-containing antacids decreases rosuvastatin plasma concentrations by approximately 50%. The FDA label recommends dosing antacids at least 2 hours after rosuvastatin [2].

Warfarin

Rosuvastatin may increase INR in patients on warfarin. INR should be monitored when initiating or adjusting rosuvastatin dose in anticoagulated patients [2].